Cheryl Xu Biography and Net Worth

Cheryl Xu is a director who currently serves as Biogen's VP of Public Policy & Government Affairs. Previously, she ran a consulting business advising multinational companies on market access and expansion in China. She has also provided consultations to the US and Chinese governments on pharmaceutical policies, and was the Director of International Finance at Pharmacia. She holds a B.S. in Physics from Peking University and an MBA in Finance from Washington University.

What is Cheryl Xu's net worth?: The estimated net worth of Cheryl Xu is at least $3.85 thousand as of June 3rd, 2025. Ms. Xu owns 3,954 shares of 60 Degrees Pharmaceuticals stock worth more than $3,845 as of October 9th. This net worth estimate does not reflect any other investments that Ms. Xu may own. Learn More about Cheryl Xu's net worth.
How do I contact Cheryl Xu?: The corporate mailing address for Ms. Xu and other 60 Degrees Pharmaceuticals executives is 1025 Connecticut Avenue NW, Suite 1000, Washington, DC, 20036. 60 Degrees Pharmaceuticals can also be reached via phone at 202-327-5422 and via email at [email protected]. Learn More on Cheryl Xu's contact information.
Has Cheryl Xu been buying or selling shares of 60 Degrees Pharmaceuticals?: Cheryl Xu has not been actively trading shares of 60 Degrees Pharmaceuticals during the last ninety days. Most recently, on Tuesday, June 3rd, Cheryl Xu bought 1,250 shares of 60 Degrees Pharmaceuticals stock. The stock was acquired at an average cost of $11.52 per share, with a total value of $14,400.00. Following the completion of the transaction, the director now directly owns 3,954 shares of the company's stock, valued at $45,550.08. Learn More on Cheryl Xu's trading history.
Are insiders buying or selling shares of 60 Degrees Pharmaceuticals?: In the last twelve months, 60 Degrees Pharmaceuticals insiders bought shares 4 times. They purchased a total of 13,007 shares worth more than $30,081.04. The most recent insider tranaction occured on June, 12th when CEO Geoffrey S Dow bought 7,350 shares worth more than $10,143.00. Insiders at 60 Degrees Pharmaceuticals own 1.7% of the company. Learn More about insider trades at 60 Degrees Pharmaceuticals.
Information on this page was last updated on 6/12/2026.

Cheryl Xu Insider Trading History at 60 Degrees Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/3/2025	Buy	1,250	$11.52	$14,400.00	3,954
12/16/2024	Buy	100	$29.00	$2,900.00	2,703
12/12/2024	Buy	250	$36.40	$9,100.00	2,303
8/27/2024	Buy	250	$34.00	$8,500.00	2,053

Cheryl Xu Buying and Selling Activity at 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Company Overview

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

Today's Range

Now: $0.98

$0.98

50 Day Range

MA: $1.09

$0.85

$1.44

2 Week Range

Now: $0.98

$0.84

$8.62

Volume

308 shs

Average Volume

1,524,562 shs

Market Capitalization

$3.45 million

P/E Ratio

N/A

Dividend Yield